L-Arginine supplementation in mice enhances NO production in spleen cells and inhibits Plasmodium yoelii transmission in mosquitoes

Parasites and Vectors

Volumn 8, Issue 1, 2015, Pages

  Zheng, Li ^a   Pan, Yanyan ^a   Feng, Yonghui ^a   Cui, Liwang ^a,b   Cao, Yaming ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Blood stage; Immune regulation; L Arginine; Mosquito; Plasmodium yoelii

Indexed keywords

ARGINASE 1; ARGININE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOPHELES STEPHENSI; ARGINASE 1 GENE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; FEMALE; GAMETOCYTE; GENETIC TRANSCRIPTION; IN VITRO STUDY; INOS GENE; MOUSE; NONHUMAN; PARASITE IMMUNITY; PARASITE TRANSMISSION; PLASMODIUM YOELII; PLASMODIUM YOELII INFECTION; SPLEEN CELL; ANIMAL; ANOPHELES; BAGG ALBINO MOUSE; GROWTH, DEVELOPMENT AND AGING; HUMAN; INSECT VECTOR; MALARIA; MALE; METABOLISM; PARASITOLOGY; PHYSIOLOGY; SPLEEN; TRANSMISSION;

MUS; PLASMODIUM YOELII;

ANIMALS; ANOPHELES; ARGININE; FEMALE; HUMANS; INSECT VECTORS; MALARIA; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; PLASMODIUM YOELII; SPLEEN;

EID: 84934923500     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/s13071-015-0940-0     Document Type: Article

References (22)

1. WHO. World malaria report 2013. 2014.
2. Purdy M, Robinson M, Wei K, Rublin D. The economic case for combating malaria. Am J Trop Med Hyg. 2013;89(5):819-23.
3. Sinden RE. Sexual development of malarial parasites. Adv Parasitol. 1983;22:153-216.
4. Carter R, Mendis KN, Miller LH, Molineaux L, Saul A. Malaria transmission-blocking vaccines-how can their development be supported? Nat Med. 2000;6(3):241-4.
5. Omodeo-Sale F, Cortelezzi L, Vommaro Z, Scaccabarozzi D, Dondorp AM. Dysregulation of L-arginine metabolism and bioavailability associated to free plasma heme. Am J Physiol Cell Physiol. 2010;299(1):C148-54.
6. Coburn LA, Gong X, Singh K, Asim M, Scull BP, Allaman MM, et al. L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis. PLoS One. 2012;7(3), e33546.
7. Weinberg JB, Lopansri BK, Mwaikambo E, Granger DL. Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria. Curr Opin Infect Dis. 2008;21(5):468-75.
8. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, et al. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med. 2007;204(11):2693-704.
9. Zhu X, Pan Y, Li Y, Cui L, Cao Y. Supplement of L-Arg improves protective immunity during early-stage Plasmodium yoelii 17XL infection. Parasite Immunol. 2012;34(8-9):412-20.
10. Cao Y, Tsuboi T, Torii M. Nitric oxide inhibits the development of Plasmodium yoelii gametocytes into gametes. Parasitol Int. 1998;47(2):157-66.
11. Boger RH, Bode-Boger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol. 2001;41:79-99.
12. Ma SH, Zheng L, Liu YJ, Guo SY, Feng H, Chen G, et al. Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice. Exp Parasitol. 2007;116(3):266-72.
13. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-8.
14. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611-22.
15. Ranawaka GR, Fleck SL, Blanco AR, Sinden RE. Characterization of the modes of action of anti-Pbs21 malaria transmission-blocking immunity: ookinete to oocyst differentiation in vivo. Parasitology. 1994;109(Pt 4):403-11.
16. Perez-Mazliah D, Langhorne J. CD4 T-cell subsets in malaria: TH1/TH2 revisited. Front Immunol. 2014;5:671.
17. Malhotra I, Mungai P, Muchiri E, Ouma J, Sharma S, Kazura JW, et al. Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands. Infect Immun. 2005;73(6):3462-70.
18. Chua CL, Brown G, Hamilton JA, Rogerson S, Boeuf P. Monocytes and macrophages in malaria: protection or pathology? Trends Parasitol. 2013;29(1):26-34.
19. Aldridge JR, Vogel IA. Macrophage biology and their activation by protozoan-derived glycosylphosphatidylinositol anchors and hemozoin. J Parasitol. 2014;100(6):737-42.
20. Zheng L, Feng H, Liu D, Pan YY, Cao YM. The expression of malarial invasion-related molecules is affected by two different nitric oxide-based treatments. Folia Parasitol. 2013;60(3):213-7.
21. Motard A, Landau I, Nussler A, Grau G, Baccam D, Mazier D, et al. The role of reactive nitrogen intermediates in modulation of gametocyte infectivity of rodent malaria parasites. Parasite Immunol. 1993;15(1):21-6.
22. Martins YC, Zanini GM, Frangos JA, Carvalho LJ. Efficacy of different nitric oxide-based strategies in preventing experimental cerebral malaria by Plasmodium berghei ANKA. PLoS One. 2012;7(2), e32048.